Metacrine is a clinical-stage biopharmaceutical company focused on discovering and developing differentiated therapies for patients with liver and gastrointestinal (GI) diseases.
For more details on financing and valuation for Metacrine, register or login.
By registering, you agree to Forge’s Terms of Use. Already registered? Log in
MTCR
0.4949 as of 2/8/23
To read this article and more news on Metacrine, register or login.
